Use of a universal targeting CAR T cell to simultaneously kill cancer cells and cancer-associated fibroblasts
CAR T cells therapies have demonstrated success in treating hematologic malignancies, but have proven less effective in eradicating solid tumors. While suppressive immune cells may contribute to reduced CAR T cell efficacies in malignant masses, cancer…